Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Philip Scheltens

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Anatomy

Chemicals & Drugs

Physiology

Disease Progression

Procedures

Brain Mapping

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Yaqub Maqsood; Tolboom Nelleke; van Berckel Bart N M; Scheltens Philip; Lammertsma Adriaan A; Boellaard Ronald
Simplified parametric methods for [18F]FDDNP studies.
Bierman E J M; Comijs H C; Jonker C; Scheltens P; Beekman A T F
The effect of anxiety and depression on decline of memory function in Alzheimer's disease.
Bouwman Femke H; Schoonenboom Niki S M; Verwey Nicolaas A; van Elk Evert J; Kok Astrid; Blankenstein Marinus A; Scheltens Philip; van der Flier Wiesje M
CSF biomarker levels in early and late onset Alzheimer's disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Philip Scheltens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Yaqub Maqsood; Tolboom Nelleke; van Berckel Bart N M; Scheltens Philip; Lammertsma Adriaan A; Boellaard Ronald
Simplified parametric methods for [18F]FDDNP studies.
NeuroImage 2010;49(1):433-41.
2009: Bierman E J M; Comijs H C; Jonker C; Scheltens P; Beekman A T F
The effect of anxiety and depression on decline of memory function in Alzheimer's disease.
International psychogeriatrics / IPA 2009;21(6):1142-7.
2009: Bouwman Femke H; Schoonenboom Niki S M; Verwey Nicolaas A; van Elk Evert J; Kok Astrid; Blankenstein Marinus A; Scheltens Philip; van der Flier Wiesje M
CSF biomarker levels in early and late onset Alzheimer's disease.
Neurobiology of aging 2009;30(12):1895-901.
2009: Gauthier Serge; Scheltens Philip
Can we do better in developing new drugs for Alzheimer's disease?
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(6):489-91.
2009: van Exel Eric; Eikelenboom Piet; Comijs Hannie; Frölich Marijke; Smit Johannes H; Stek Max L; Scheltens Philip; Eefsting Jan E; Westendorp Rudi G J
Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
Archives of general psychiatry 2009;66(11):1263-70.
2009: Goos Jeroen D C; Kester M I; Barkhof Frederik; Klein Martin; Blankenstein Marinus A; Scheltens Philip; van der Flier Wiesje M
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition.
Stroke; a journal of cerebral circulation 2009;40(11):3455-60.
2009: Mulder Sandra D; Heijst Johannes A; Mulder Cees; Martens Frans; Hack C Erik; Scheltens Philip; Blankenstein Marinus A; Veerhuis Robert
CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease.
Annals of clinical biochemistry 2009;46(Pt 6):477-83.
2009: van der Vlies A E; Koedam E L G E; Pijnenburg Y A L; Twisk J W R; Scheltens P; van der Flier W M
Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
Psychological medicine 2009;39(11):1907-11.
2009: Schuitemaker Alie; Dik Miranda G; Veerhuis Robert; Scheltens Philip; Schoonenboom Niki S M; Hack C Erik; Blankenstein Marinus A; Jonker Cees
Inflammatory markers in AD and MCI patients with different biomarker profiles.
Neurobiology of aging 2009;30(11):1885-9.
2009: Kester M I; van der Vlies A E; Blankenstein M A; Pijnenburg Y A L; van Elk E J; Scheltens P; van der Flier W M
CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
Neurology 2009;73(17):1353-8.
2009: Wattjes Mike P; Henneman Wouter J P; van der Flier Wiesje M; de Vries Oscar; Träber Frank; Geurts Jeroen J G; Scheltens Philip; Vrenken Hugo; Barkhof Frederik
Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT.
Radiology 2009;253(1):174-83.
2009: van de Pol L A; Verhey F; Frisoni G B; Tsolaki M; Papapostolou P; Nobili F; Wahlund L-O; Minthon L; Frölich L; Hampel H; Soininen H; Knol D L; Barkhof F; Scheltens P; Visser P J
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.
Journal of neurology, neurosurgery, and psychiatry 2009;80(10):1069-74.
2009: Tolboom Nelleke; Yaqub Maqsood; Boellaard Ronald; Luurtsema Gert; Windhorst Albert D; Scheltens Philip; Lammertsma Adriaan A; van Berckel Bart N M
Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease.
European journal of nuclear medicine and molecular imaging 2009;36(10):1629-38.
2009: Henneman W J P; Vrenken H; Barnes J; Sluimer I C; Verwey N A; Blankenstein M A; Klein M; Fox N C; Scheltens P; Barkhof F; van der Flier W M
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.
Neurology 2009;73(12):935-40.
2009: Scheltens P
Moving forward with nutrition in Alzheimer's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16 Suppl 1():19-22.
2009: Scheltens P
Nutrition and dementia.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16 Suppl 1():iii-iv.
2009: Tolboom Nelleke; van der Flier Wiesje M; Yaqub Maqsood; Boellaard Ronald; Verwey Nicolaas A; Blankenstein Marinus A; Windhorst Albert D; Scheltens Philip; Lammertsma Adriaan A; van Berckel Bart N M
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(9):1464-70.
2009: Yaqub Maqsood; Boellaard Ronald; van Berckel Bart N M; Tolboom Nelleke; Luurtsema Gert; Dijkstra Anke A; Lubberink Mark; Windhorst Albert D; Scheltens Philip; Lammertsma Adriaan A
Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(5):322-33.
2009: Kester Maartje I; Scheltens Philip
Dementia: the bare essentials.
Practical neurology 2009;9(4):241-51.
2009: Verwey Nicolaas A; Veerhuis Robert; Twaalfhoven Harry A M; Wouters Dorine; Hoozemans Jeroen J M; Bollen Yves J M; Killestein Joep; Bibl Mirko; Wiltfang Jens; Hack C Erik; Scheltens Philip; Blankenstein Marinus A
Quantification of amyloid-beta 40 in cerebrospinal fluid.
Journal of immunological methods 2009;348(1-2):57-66.
2009: Mattsson Niklas; Zetterberg Henrik; Hansson Oskar; Andreasen Niels; Parnetti Lucilla; Jonsson Michael; Herukka Sanna-Kaisa; van der Flier Wiesje M; Blankenstein Marinus A; Ewers Michael; Rich Kenneth; Kaiser Elmar; Verbeek Marcel; Tsolaki Magda; Mulugeta Ezra; Rosén Erik; Aarsland Dag; Visser Pieter Jelle; Schröder Johannes; Marcusson Jan; de Leon Mony; Hampel Harald; Scheltens Philip; Pirttilä Tuula; Wallin Anders; Jönhagen Maria Eriksdotter; Minthon Lennart; Winblad Bengt; Blennow Kaj
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
JAMA : the journal of the American Medical Association 2009;302(4):385-93.
2009: van der Flier Wiesje M; Scheltens Philip
Alzheimer disease: Hippocampal volume loss and Alzheimer disease progression.
Nature reviews. Neurology 2009;5(7):361-2.
2009: Visser Pieter Jelle; Verhey Frans; Knol Dirk L; Scheltens Philip; Wahlund Lars-Olof; Freund-Levi Yvonne; Tsolaki Magda; Minthon Lennart; Wallin Asa K; Hampel Harald; Bürger Katharina; Pirttila Tuula; Soininen Hilkka; Rikkert Marcel Olde; Verbeek Marcel M; Spiru Luiza; Blennow Kaj
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Lancet neurology 2009;8(7):619-27.
2009: Chan Dennis; Anderson Valerie; Pijnenburg Yolande; Whitwell Jennifer; Barnes Jo; Scahill Rachael; Stevens John M; Barkhof Frederik; Scheltens Philip; Rossor Martin N; Fox Nick C
The clinical profile of right temporal lobe atrophy.
Brain : a journal of neurology 2009;132(Pt 5):1287-98.
2009: Staekenborg Salka S; Koedam Esther L G E; Henneman Wouter J P; Stokman Pauline; Barkhof Frederik; Scheltens Philip; van der Flier Wiesje M
Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
Stroke; a journal of cerebral circulation 2009;40(4):1269-74.
2009: Damoiseaux Jessica S; Smith Stephen M; Witter Menno P; Sanz-Arigita Ernesto J; Barkhof Frederik; Scheltens Philip; Stam Cornelis J; Zarei Mojtaba; Rombouts Serge A R B
White matter tract integrity in aging and Alzheimer's disease.
Human brain mapping 2009;30(4):1051-9.
2009: van der Vlies A E; Verwey N A; Bouwman F H; Blankenstein M A; Klein M; Scheltens P; van der Flier W M
CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
Neurology 2009;72(12):1056-61.
2009: Henneman W J P; Sluimer J D; Barnes J; van der Flier W M; Sluimer I C; Fox N C; Scheltens P; Vrenken H; Barkhof F
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
Neurology 2009;72(11):999-1007.
2009: Kester Maartje I; Blankenstein Marinus A; Bouwman Femke H; van Elk Evert J; Scheltens Philip; van der Flier Wiesje M
CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.
Journal of Alzheimer's disease : JAD 2009;16(3):601-7.
2009: Zarei Mojtaba; Damoiseaux Jeske S; Morgese Ciro; Beckmann Christian F; Smith Steve M; Matthews Paul M; Scheltens Philip; Rombouts Serge A R B; Barkhof Frederik
Regional white matter integrity differentiates between vascular dementia and Alzheimer disease.
Stroke; a journal of cerebral circulation 2009;40(3):773-9.
2009: Montez Teresa; Poil Simon-Shlomo; Jones Bethany F; Manshanden Ilonka; Verbunt Jeroen P A; van Dijk Bob W; Brussaard Arjen B; van Ooyen Arjen; Stam Cornelis J; Scheltens Philip; Linkenkaer-Hansen Klaus
Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(5):1614-9.
2009: Tolboom Nelleke; Yaqub Maqsood; van der Flier Wiesje M; Boellaard Ronald; Luurtsema Gert; Windhorst Albert D; Barkhof Frederik; Scheltens Philip; Lammertsma Adriaan A; van Berckel Bart N M
Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(2):191-7.
2009: Ropele Stefan; Seewann Alexandra; Gouw Alida A; van der Flier Wiesje M; Schmidt Reinhold; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo; Scheltens Philip; Wahlund Lars O; Waldemar Gunhild; Chabriat Hugues; Ferro José; Hennerici Michael; O'Brien John; Wallin Anders; Langhorne Peter; Visser Marieke C; Barkhof Frederik; Fazekas Franz;
Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study.
Journal of magnetic resonance imaging : JMRI 2009;29(2):268-74.
2009: Henneman Wouter J P; Sluimer Jasper D; Cordonnier Charlotte; Baak Merel M E; Scheltens Philip; Barkhof Frederik; van der Flier Wiesje M
MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.
Stroke; a journal of cerebral circulation 2009;40(2):492-8.
2009: Stam C J; de Haan W; Daffertshofer A; Jones B F; Manshanden I; van Cappellen van Walsum A M; Montez T; Verbunt J P A; de Munck J C; van Dijk B W; Berendse H W; Scheltens P
Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease.
Brain : a journal of neurology 2009;132(Pt 1):213-24.
2009: Rombouts Serge A R B; Damoiseaux Jessica S; Goekoop Rutger; Barkhof Frederik; Scheltens Philip; Smith Stephen M; Beckmann Christian F
Model-free group analysis shows altered BOLD FMRI networks in dementia.
Human brain mapping 2009;30(1):256-66.
2009: de Haan Willem; Pijnenburg Yolande A L; Strijers Rob L M; van der Made Yolande; van der Flier Wiesje M; Scheltens Philip; Stam Cornelis J
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory.
BMC neuroscience 2009;10():101.
2009: Scheltens Philip
Imaging in Alzheimer's disease.
Dialogues in clinical neuroscience 2009;11(2):191-9.
2009: Inzitari Domenico; Pracucci Giovanni; Poggesi Anna; Carlucci Giovanna; Barkhof Frederik; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Ferro José M; Hennerici Michael; Langhorne Peter; O'Brien John; Scheltens Philip; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Pantoni Leonardo;
Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.
BMJ (Clinical research ed.) 2009;339():b2477.
2009: Jokinen Hanna; Kalska Hely; Ylikoski Raija; Madureira Sofia; Verdelho Ana; van der Flier Wiesje M; Scheltens Philip; Barkhof Frederik; Visser Marieke C; Fazekas Franz; Schmidt Reinhold; O'Brien John; Waldemar Gunhild; Wallin Anders; Chabriat Hugues; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(4):384-91.
2009: Jokinen Hanna; Kalska Hely; Ylikoski Raija; Madureira Sofia; Verdelho Ana; Gouw Alida; Scheltens Philip; Barkhof Frederik; Visser Marieke C; Fazekas Franz; Schmidt Reinhold; O'Brien John; Hennerici Michael; Baezner Hansjorg; Waldemar Gunhild; Wallin Anders; Chabriat Hugues; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(4):336-44.
2009: Liedorp M; van der Flier W M; Hoogervorst E L J; Scheltens P; Stam C J
Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohort.
Dementia and geriatric cognitive disorders 2009;27(1):18-23.
2008: Gouw Alida A; van der Flier Wiesje M; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo; Wahlund Lars O; Waldemar Gunhild; Schmidt Reinhold; Fazekas Franz; Scheltens Philip; Barkhof Frederik;
On the etiology of incident brain lacunes: longitudinal observations from the LADIS study.
Stroke; a journal of cerebral circulation 2008;39(11):3083-5.
2008: Staekenborg S S; van Straaten E C W; van der Flier W M; Lane R; Barkhof F; Scheltens P
Small vessel versus large vessel vascular dementia: risk factors and MRI findings.
Journal of neurology 2008;255(11):1644-51; discussion 1813-4.
2008: Oosterman Joukje M; Vogels Raymond L C; van Harten Barbera; Gouw Alida A; Scheltens Philip; Poggesi Anna; Weinstein Henry C; Scherder Erik J A
The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
Brain and cognition 2008;68(2):128-33.
2008: Poggesi Anna; Pracucci Giovanni; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Verdelho Ana; Hennerici Michael; Langhorne Peter; O'Brien John; Scheltens Philip; Visser Marieke C; Crisby Milita; Waldemar Gunhild; Wallin Anders; Inzitari Domenico; Pantoni Leonardo;
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study.
Journal of the American Geriatrics Society 2008;56(9):1638-43.
2008: Ballard C; Sauter M; Scheltens P; He Y; Barkhof F; van Straaten E C W; van der Flier W M; Hsu C; Wu S; Lane R
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study.
Current medical research and opinion 2008;24(9):2561-74.
2008: Ryberg C; Rostrup E; Sjöstrand K; Paulson O B; Barkhof F; Scheltens P; van Straaten E C W; Fazekas F; Schmidt R; Erkinjuntti T; Wahlund L-O; Basile A M; Pantoni L; Inzitari D; Waldemar G;
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study.
AJNR. American journal of neuroradiology 2008;29(8):1498-504.
2008: de Haan Willem; Stam Cornelis J; Jones Bethany F; Zuiderwijk Ilonka M; van Dijk Bob W; Scheltens Philip
Resting-state oscillatory brain dynamics in Alzheimer disease.
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2008;25(4):187-93.
2008: Gauthier Serge; Dubois Bruno; Feldman Howard; Scheltens Philip
Revised research diagnostic criteria for Alzheimer's disease.
Lancet neurology 2008;7(8):668-70.
2008: Sluimer Jasper D; van der Flier Wiesje M; Karas Giorgos B; Fox Nick C; Scheltens Philip; Barkhof Frederik; Vrenken Hugo
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
Radiology 2008;248(2):590-8.
2008: Yaqub Maqsood; Tolboom Nelleke; Boellaard Ronald; van Berckel Bart N M; van Tilburg Erica W; Luurtsema Gert; Scheltens Philip; Lammertsma Adriaan A
Simplified parametric methods for [11C]PIB studies.
NeuroImage 2008;42(1):76-86.
2008: Pijnenburg Yolande A L; Strijers Rob L M; Made Yolande Vd; van der Flier Wiesje M; Scheltens Philip; Stam Cornelis J
Investigation of resting-state EEG functional connectivity in frontotemporal lobar degeneration.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2008;119(8):1732-8.
2008: Bastos-Leite A J; Kuijer J P A; Rombouts S A R B; Sanz-Arigita E; van Straaten E C; Gouw A A; van der Flier W M; Scheltens P; Barkhof F
Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities.
AJNR. American journal of neuroradiology 2008;29(7):1296-301.
2008: Miranda B; Madureira S; Verdelho A; Ferro J; Pantoni L; Salvadori E; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Scheltens P; Visser M C; Wahlund L-O; Waldemar G; Wallin A; Inzitarion D;
Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes.
Journal of neurology, neurosurgery, and psychiatry 2008;79(8):869-73.
2008: Damoiseaux J S; Beckmann C F; Arigita E J Sanz; Barkhof F; Scheltens Ph; Stam C J; Smith S M; Rombouts S A R B
Reduced resting-state brain activity in the "default network" in normal aging.
Cerebral cortex (New York, N.Y. : 1991) 2008;18(8):1856-64.
2008: Oosterman J; van Harten B; Vogels R; Gouw A; Weinstein H; Scheltens P; Scherder E
Distortions in rest-activity rhythm in aging relate to white matter hyperintensities.
Neurobiology of aging 2008;29(8):1265-71.
2008: Frisoni Giovanni B; Henneman Wouter J P; Weiner Michael W; Scheltens Philip; Vellas Bruno; Reynish Emma; Hudecova Jaroslava; Hampel Harald; Burger Katharina; Blennow Kaj; Waldemar Gunhild; Johannsen Peter; Wahlund Lars-Olof; Zito Giancarlo; Rossini Paolo M; Winblad Bengt; Barkhof Frederik;
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(4):255-64.
2008: Brenner David; Labreuche Julien; Pico Fernando; Scheltens Philip; Poirier Odette; Cambien François; Amarenco Pierre;
The renin-angiotensin-aldosterone system in cerebral small vessel disease.
Journal of neurology 2008;255(7):993-1000.
2008: Sluimer J D; Vrenken H; Blankenstein M A; Fox N C; Scheltens P; Barkhof F; van der Flier W M
Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.
Neurology 2008;70(19 Pt 2):1836-41.
2008: Oosterman Joukje M; Van Harten Barbera; Weinstein Henry C; Scheltens Philip; Sergeant Joseph A; Scherder Erik J A
White matter hyperintensities and working memory: an explorative study.
Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition 2008;15(3):384-99.
2008: Wessels Alette M; Scheltens Philip; Barkhof Frederik; Heine Robert J
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
European journal of pharmacology 2008;585(1):88-96.
2008: Gouw Alida A; van der Flier Wiesje M; Fazekas Franz; van Straaten Elisabeth C W; Pantoni Leonardo; Poggesi Anna; Inzitari Domenico; Erkinjuntti Timo; Wahlund Lars O; Waldemar Gunhild; Schmidt Reinhold; Scheltens Philip; Barkhof Frederik;
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
Stroke; a journal of cerebral circulation 2008;39(5):1414-20.
2008: Karas G; Sluimer J; Goekoop R; van der Flier W; Rombouts S A R B; Vrenken H; Scheltens P; Fox N; Barkhof F
Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.
AJNR. American journal of neuroradiology 2008;29(5):944-9.
2008: Schoonenboom Niki S M; van der Flier Wiesje M; Blankenstein Marinus A; Bouwman Femke H; Van Kamp Gerard J; Barkhof Frederik; Scheltens Philip
CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
Neurobiology of aging 2008;29(5):669-75.
2008: Jelles B; Scheltens Ph; van der Flier W M; Jonkman E J; da Silva F H Lopes; Stam C J
Global dynamical analysis of the EEG in Alzheimer's disease: frequency-specific changes of functional interactions.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2008;119(4):837-41.
2008: Staekenborg Salka S; Gillissen Freek; Romkes Rolinka; Pijnenburg Yolande A L; Barkhof Frederik; Scheltens Philip; van der Flier Wiesje M
Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
International journal of geriatric psychiatry 2008;23(4):387-92.
2008: Roks G; Korf E S C; van der Flier W M; Scheltens P; Stam C J
The use of EEG in the diagnosis of dementia with Lewy bodies.
Journal of neurology, neurosurgery, and psychiatry 2008;79(4):377-80.
2008: Vogels Raymond L C; Oosterman Joukje M; Laman David M; Gouw Alida A; Schroeder-Tanka Jutta M; Scheltens Philip; van der Flier Wiesje M; Weinstein Henry C
Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performance.
Congestive heart failure (Greenwich, Conn.) 2008;14(2):61-5.
2008: Baezner H; Blahak C; Poggesi A; Pantoni L; Inzitari D; Chabriat H; Erkinjuntti T; Fazekas F; Ferro J M; Langhorne P; O'Brien J; Scheltens P; Visser M C; Wahlund L O; Waldemar G; Wallin A; Hennerici M G;
Association of gait and balance disorders with age-related white matter changes: the LADIS study.
Neurology 2008;70(12):935-42.
2008: Staekenborg Salka S; van der Flier Wiesje M; van Straaten Elisabeth C W; Lane Roger; Barkhof Frederik; Scheltens Philip
Neurological signs in relation to type of cerebrovascular disease in vascular dementia.
Stroke; a journal of cerebral circulation 2008;39(2):317-22.
2008: van Eijsden P; Veldink J H; Linn F H; Scheltens P; Biessels G J
Progressive dementia and mesiotemporal atrophy on brain MRI: neurosyphilis mimicking pre-senile Alzheimer's disease?
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(2):e14-5.
2008: Draskovic Irena; Vernooij-Dassen Myrra; Verhey Frans; Scheltens Philip; Rikkert Marcel Olde
Development of quality indicators for memory clinics.
International journal of geriatric psychiatry 2008;23(2):119-28.
2008: Griëntschnig C G; Scheltens Ph; van der Waal I
[Atypical pain in the mandible caused by trigeminal neuralgia]
Nederlands tijdschrift voor tandheelkunde 2008;115(1):41-3.
2008: Verwey Nicolaas A; Schuitemaker Alie; van der Flier Wiesje M; Mulder Sandra D; Mulder Cees; Hack C Erik; Scheltens Philip; Blankenstein Marinus A; Veerhuis Robert
Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Dementia and geriatric cognitive disorders 2008;26(6):522-7.
2008: Galluzzi Samantha; Talassi Erika; Belussi Michela; Scheltens Philip; van de Pol Laura; Nobili Flavio; Rodriguez Guido; Froelich Lutz; Damian Marinella; Martinez-Lage Pablo; Gomez-Isla Teresa; Reynish Emma; Ousset Pierre Jean; Vellas Bruno; Frisoni Giovanni B
Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study.
Dementia and geriatric cognitive disorders 2008;26(4):314-22.
2008: Koedam Esther L G E; Pijnenburg Yolande A L; Deeg Dorly J H; Baak Merel M E; van der Vlies Annelies E; Scheltens Philip; van der Flier Wiesje M
Early-onset dementia is associated with higher mortality.
Dementia and geriatric cognitive disorders 2008;26(2):147-52.
2008: Karas Giorgos; Scheltens Philip; Barkhof Frederik
Feature extraction and strategy of analyzing structural neuroimaging in dementia.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2008;89():75-86.
2008: Verwey Nicolaas A; Bouwman Femke H; van der Flier Wiesje M; Veerhuis Rob; Scheltens Philip; Blankenstein Marinus A
Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(9):1300-4.
2008: Visser P J; Verhey F R J; Boada M; Bullock R; De Deyn P P; Frisoni G B; Frolich L; Hampel H; Jolles J; Jones R; Minthon L; Nobili F; Olde Rikkert M; Ousset P-J; Rigaud A-S; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Wahlund L-O; Wilcock G; Winblad B
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.
Neuroepidemiology 2008;30(4):254-65.
2008: van der Flier W M; Pijnenburg Y A L; Schoonenboom S N M; Dik M G; Blankenstein M A; Scheltens P
Distribution of APOE genotypes in a memory clinic cohort.
Dementia and geriatric cognitive disorders 2008;25(5):433-8.
2008: Jacova Claudia; Peters Kevin R; Beattie B Lynn; Wong Erick; Riddehough Andrew; Foti Dean; Scheltens Philip; Li David K B; Feldman Howard H
Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
Dementia and geriatric cognitive disorders 2008;25(3):238-47.
2008: Gouw A A; van der Flier W M; van Straaten E C W; Pantoni L; Bastos-Leite A J; Inzitari D; Erkinjuntti T; Wahlund L O; Ryberg C; Schmidt R; Fazekas F; Scheltens P; Barkhof F;
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression.
Cerebrovascular diseases (Basel, Switzerland) 2008;25(3):247-53.
2008: Joling Karlijn J; van Hout Hein P J; Scheltens Philip; Vernooij-Dassen Myrra; van den Berg Bernard; Bosmans Judith; Gillissen Freek; Mittelman Mary; van Marwijk Harm W J
(Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial.
BMC geriatrics 2008;8():2.
2008: Pijnenburg Yolande A L; Mulder Jacqueline L; van Swieten John C; Uitdehaag Bernard M J; Stevens Martijn; Scheltens Philip; Jonker Cees
Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population.
Dementia and geriatric cognitive disorders 2008;25(2):157-64.
2007: Ewers M; Buerger K; Teipel S J; Scheltens P; Schröder J; Zinkowski R P; Bouwman F H; Schönknecht P; Schoonenboom N S M; Andreasen N; Wallin A; DeBernardis J F; Kerkman D J; Heindl B; Blennow K; Hampel H
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.
Neurology 2007;69(24):2205-12.
2007: Teunissen Charlotte E; Scheltens Philip
Use of proteomic approaches to identify disease biomarkers.
Lancet neurology 2007;6(12):1036-7.
2007: Bastos-Leite António J; van der Flier Wiesje M; van Straaten Elisabeth C W; Staekenborg Salka S; Scheltens Philip; Barkhof Frederik
The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.
Stroke; a journal of cerebral circulation 2007;38(12):3182-5.
2007: Karas Giorgos; Scheltens Philip; Rombouts Serge; van Schijndel Ronald; Klein Martin; Jones Bethany; van der Flier Wiesje; Vrenken Hugo; Barkhof Frederik
Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study.
Neuroradiology 2007;49(12):967-76.
2007: Verdelho Ana; Madureira Sofia; Ferro José M; Basile Anna-Maria; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Hennerici Michael; O'Brien John; Pantoni Leonardo; Salvadori Emilia; Scheltens Philip; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Inzitari Domenico;
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
Journal of neurology, neurosurgery, and psychiatry 2007;78(12):1325-30.
2007: Kropholler Marc A; Boellaard Ronald; van Berckel Bart N M; Schuitemaker Alie; Kloet Reina W; Lubberink Mark J; Jonker Cees; Scheltens Philip; Lammertsma Adriaan A
Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(12):1965-74.
2007: Rombouts Serge A R B; Scheltens Philip; Kuijer Joost P A; Barkhof Frederik
Whole brain analysis of T2* weighted baseline FMRI signal in dementia.
Human brain mapping 2007;28(12):1313-7.
2007: Vogels Raymond L C; Oosterman Joukje M; van Harten Barbera; Scheltens Philip; van der Flier Wiesje M; Schroeder-Tanka Jutta M; Weinstein Henry C
Profile of cognitive impairment in chronic heart failure.
Journal of the American Geriatrics Society 2007;55(11):1764-70.
2007: Verhey F R J; Ramakers I; Jolles J; Scheltens P; Vernooij-Dassen M; Olde Rikkert M
[Development of memory clinics in The Netherlands]
Tijdschrift voor gerontologie en geriatrie 2007;38(5):237-45.
2007: Barkhof F; Polvikoski T M; van Straaten E C W; Kalaria R N; Sulkava R; Aronen H J; Niinistö L; Rastas S; Oinas M; Scheltens P; Erkinjuntti T
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old.
Neurology 2007;69(15):1521-7.
2007: van de Pol L A; van der Flier W M; Korf E S C; Fox N C; Barkhof F; Scheltens P
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
Neurology 2007;69(15):1491-7.
2007: Hagenbeek R E; Rombouts S A R B; Veltman D J; Van Strien J W; Witter M P; Scheltens P; Barkhof F
Nonlinear changes in brain activity during continuous word repetition: an event-related multiparametric functional MR imaging study.
AJNR. American journal of neuroradiology 2007;28(9):1715-21.
2007: Scheltens Philip
Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2007;78(10):1039.
2007: Vogels Raymond L C; van der Flier Wiesje M; van Harten Barbera; Gouw Alida A; Scheltens Philip; Schroeder-Tanka Jutta M; Weinstein Henry C
Brain magnetic resonance imaging abnormalities in patients with heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(10):1003-9.
2007: Bouwman F H; van der Flier W M; Schoonenboom N S M; van Elk E J; Kok A; Rijmen F; Blankenstein M A; Scheltens P
Longitudinal changes of CSF biomarkers in memory clinic patients.
Neurology 2007;69(10):1006-11.
2007: Schuitemaker Alie; van Berckel Bart N M; Kropholler Marc A; Kloet Reina W; Jonker Cees; Scheltens Philip; Lammertsma Adriaan A; Boellaard Ronald
Evaluation of methods for generating parametric (R-[11C]PK11195 binding images.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(9):1603-15.
2007: Dubois Bruno; Feldman Howard H; Jacova Claudia; Dekosky Steven T; Barberger-Gateau Pascale; Cummings Jeffrey; Delacourte André; Galasko Douglas; Gauthier Serge; Jicha Gregory; Meguro Kenichi; O'brien John; Pasquier Florence; Robert Philippe; Rossor Martin; Salloway Steven; Stern Yaakov; Visser Pieter J; Scheltens Philip
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Lancet neurology 2007;6(8):734-46.
2007: Wessels A M; Rombouts S A R B; Remijnse P L; Boom Y; Scheltens P; Barkhof F; Heine R J; Snoek F J
Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume.
Diabetologia 2007;50(8):1763-9.
2007: van de Pol Laura A; Korf Esther S C; van der Flier Wiesje M; Brashear H Robert; Fox Nick C; Barkhof Frederik; Scheltens Philip
Magnetic resonance imaging predictors of cognition in mild cognitive impairment.
Archives of neurology 2007;64(7):1023-8.
2007: Wessels A M; Pouwer F; Geelhoed-Duijvestijn P H L M; Snel M; Kostense P J; Scheltens P; Heine R J; Snoek F J
No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: a cross-sectional study.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(7):735-40.
2007: Pijnenburg Y A L; Schoonenboom S N M; Mehta P D; Mehta S P; Mulder C; Veerhuis R; Blankenstein M A; Scheltens P
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration.
Journal of neurology, neurosurgery, and psychiatry 2007;78(7):735-7.
2007: Bouwman F H; Schoonenboom S N M; van der Flier W M; van Elk E J; Kok A; Barkhof F; Blankenstein M A; Scheltens Ph
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.
Neurobiology of aging 2007;28(7):1070-4.
2007: Ridha Basil H; Barnes Josephine; van de Pol Laura A; Schott Jonathan M; Boyes Richard G; Siddique Musib M; Rossor Martin N; Scheltens Philip; Fox Nick C
Application of automated medial temporal lobe atrophy scale to Alzheimer disease.
Archives of neurology 2007;64(6):849-54.
2007: Mulder Cees; van der Flier Wiesje M; Veerhuis Robert; Bouwman Femke; Jakobs Cornelis; Verhoeven Nanda M; Barkhof Frederik; Scheltens Philip; Blankenstein Marinus A
Association between vitamin B6 and white matter hyperintensities in patients with Alzheimer's disease not mediated by homocysteine metabolism.
Journal of the American Geriatrics Society 2007;55(6):956-8.
2007: Feldman Howard H; Ferris Steven; Winblad Bengt; Sfikas Nikolaos; Mancione Linda; He Yunsheng; Tekin Sibel; Burns Alistair; Cummings Jeffrey; del Ser Teodoro; Inzitari Domenico; Orgogozo Jean-Marc; Sauer Heinrich; Scheltens Philip; Scarpini Elio; Herrmann Nathan; Farlow Martin; Potkin Steven; Charles H Cecil; Fox Nick C; Lane Roger
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
Lancet neurology 2007;6(6):501-12.
2007: Gootjes Liselotte; Scheltens Philip; Van Strien Jan W; Bouma Anke
Subcortical white matter pathology as a mediating factor for age-related decreased performance in dichotic listening.
Neuropsychologia 2007;45(10):2322-32.
2007: Scheltens Philip
All patients with suspected dementia should be scanned at least once with CT or MRI.
International psychogeriatrics / IPA 2007;19(3):533-4; discussion 534-8.
2007: Ryberg C; Rostrup E; Stegmann M B; Barkhof F; Scheltens P; van Straaten E C W; Fazekas F; Schmidt R; Ferro J M; Baezner H; Erkinjuntti T; Jokinen H; Wahlund L-O; O'brien J; Basile A M; Pantoni L; Inzitari D; Waldemar G;
Clinical significance of corpus callosum atrophy in a mixed elderly population.
Neurobiology of aging 2007;28(6):955-63.
2007: Scher A I; Xu Y; Korf E S C; White L R; Scheltens P; Toga A W; Thompson P M; Hartley S W; Witter M P; Valentino D J; Launer L J
Hippocampal shape analysis in Alzheimer's disease: a population-based study.
NeuroImage 2007;36(1):8-18.
2007: Schuitemaker Alie; van Berckel Bart N M; Kropholler Marc A; Veltman Dick J; Scheltens Philip; Jonker Cees; Lammertsma Adriaan A; Boellaard Ronald
SPM analysis of parametric (R)-[11C]PK11195 binding images: plasma input versus reference tissue parametric methods.
NeuroImage 2007;35(4):1473-9.
2007: Vogels Raymond L C; Scheltens Philip; Schroeder-Tanka Jutta M; Weinstein Henry C
Cognitive impairment in heart failure: a systematic review of the literature.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(5):440-9.
2007: Jokinen Hanna; Ryberg Charlotte; Kalska Hely; Ylikoski Raija; Rostrup Egill; Stegmann Mikkel B; Waldemar Gunhild; Madureira Sofia; Ferro José M; van Straaten Elizabeth C W; Scheltens Philip; Barkhof Frederik; Fazekas Franz; Schmidt Reinhold; Carlucci Giovanna; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study.
Journal of neurology, neurosurgery, and psychiatry 2007;78(5):491-6.
2007: Podewils L J; Guallar E; Beauchamp N; Lyketsos C G; Kuller L H; Scheltens P
Physical activity and white matter lesion progression: assessment using MRI.
Neurology 2007;68(15):1223-6.
2007: Verhey F R J; Scheltens P; Olde Rikkert M G M
[The development of memory clinics in The Netherlands]
Nederlands tijdschrift voor geneeskunde 2007;151(10):578-80.
2007: van Harten Barbera; Oosterman Joukje; Muslimovic Dino; van Loon Bert-Jan Potter; Scheltens Philip; Weinstein Henry C
Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus.
Age and ageing 2007;36(2):164-70.
2007: van Berckel Bart N M; Scheltens Philip
Getting a grip on Alzheimer's disease: imaging amyloid in the brain.
Lancet neurology 2007;6(3):204-6.
2007: van der Flier Wiesje M; Barkhof Frederik; Scheltens Philip
Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI.
Annals of the New York Academy of Sciences 2007;1097():215-24.
2007: Korf E S C; van Straaten E C W; de Leeuw F-E; van der Flier W M; Barkhof F; Pantoni L; Basile A M; Inzitari D; Erkinjuntti T; Wahlund L-O; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(2):166-71.
2007: van de Pol L A; Barnes J; Scahill R I; Frost C; Lewis E B; Boyes R G; van Schijndel R A; Scheltens P; Fox N C; Barkhof F
Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration.
NeuroImage 2007;34(3):1036-41.
2007: Waldemar G; Dubois B; Emre M; Georges J; McKeith I G; Rossor M; Scheltens P; Tariska P; Winblad B;
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(1):e1-26.
2007: DeCarli Charles; Frisoni Giovanni B; Clark Christopher M; Harvey Danielle; Grundman Michael; Petersen Ronald C; Thal Leon J; Jin Shelia; Jack Clifford R; Scheltens Philip;
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia.
Archives of neurology 2007;64(1):108-15.
2007: van Stegeren Anda H; Wolf Oliver T; Everaerd Walter; Scheltens Philip; Barkhof Frederik; Rombouts Serge A R B
Endogenous cortisol level interacts with noradrenergic activation in the human amygdala.
Neurobiology of learning and memory 2007;87(1):57-66.
2007: Stam C J; Jones B F; Nolte G; Breakspear M; Scheltens Ph
Small-world networks and functional connectivity in Alzheimer's disease.
Cerebral cortex (New York, N.Y. : 1991) 2007;17(1):92-9.
2007: Vogels Raymond L C; Oosterman Joukje M; van Harten Barbera; Gouw Alida A; Schroeder-Tanka Jutta M; Scheltens Philip; van der Flier Wiesje M; Weinstein Henry C
Neuroimaging and correlates of cognitive function among patients with heart failure.
Dementia and geriatric cognitive disorders 2007;24(6):418-23.
2007: van der Vlies Annelies E; Pijnenburg Yolande A L; Koene Teddy; Klein Martin; Kok Astrid; Scheltens Philip; van der Flier Wiesje M
Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
Dementia and geriatric cognitive disorders 2007;24(2):98-103.
2007: Ylikoski Raija; Jokinen Hanna; Andersen Pia; Salonen Oili; Madureira Sofia; Ferro Jose; Barkhof Frederik; van der Flier Wiesje; Schmidt Reinhold; Fazekas Franz; Scheltens Philip; Waldemar Gunhild; Salvadori Emilia; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo;
Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
Dementia and geriatric cognitive disorders 2007;24(2):73-81.
2007: Pijnenburg Yolande A L; Janssen John C; Schoonenboom Niki S M; Petzold Axel; Mulder Cees; Stigbrand Torgny; Norgren Niklas; Heijst Hans; Hack C Erik; Scheltens Philip; Teunissen Charlotte E
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.
Dementia and geriatric cognitive disorders 2007;23(4):225-30.
2007: van Harten Barbera; Oosterman Joukje M; Potter van Loon Bert-Jan; Scheltens Philip; Weinstein Henry C
Brain lesions on MRI in elderly patients with type 2 diabetes mellitus.
European neurology 2007;57(2):70-4.
2007: van der Flier Wiesje M; Staekenborg Salka; Pijnenburg Yolande A L; Gillissen Freek; Romkes Rolinka; Kok Astrid; Bouwman Femke H; Scheltens Philip
Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.
Dementia and geriatric cognitive disorders 2007;23(1):42-6.
2006: Lazeron R H C; de Sonneville L M J; Scheltens P; Polman C H; Barkhof F
Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(6):760-8.
2006: Van Dijk Koene R A; Luijpen Marijn W; Van Someren Eus J W; Sergeant Joseph A; Scheltens Philip; Scherder Erik J A
Peripheral electrical nerve stimulation and rest-activity rhythm in Alzheimer's disease.
Journal of sleep research 2006;15(4):415-23.
2006: Jones Bethany F; Barnes Josephine; Uylings Harry B M; Fox Nick C; Frost Chris; Witter Menno P; Scheltens Philip
Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study.
Cerebral cortex (New York, N.Y. : 1991) 2006;16(12):1701-8.
2006: Bastos-Leite A J; van Waesberghe J H; Oen A L; van der Flier W M; Scheltens P; Barkhof F
Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjects.
AJNR. American journal of neuroradiology 2006;27(10):2141-5.
2006: van Harten Barbera; de Leeuw Frank-Erik; Weinstein Henry C; Scheltens Philip; Biessels Geert Jan
Brain imaging in patients with diabetes: a systematic review.
Diabetes care 2006;29(11):2539-48.
2006: Oosterman Joukje M; van Harten Barbera; Weinstein Henry C; Scheltens Philip; Scherder Erik J A
Pain intensity and pain affect in relation to white matter changes.
Pain 2006;125(1-2):74-81.
2006: Korf Esther S C; White Lon R; Scheltens Ph; Launer Lenore J
Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study.
Diabetes care 2006;29(10):2268-74.
2006: Bouwman Femke H; van der Flier Wiesje M; Scheltens Philip
Can lumbar puncture help to identify patients with incipient Alzheimer's disease?
Nature clinical practice. Neurology 2006;2(10):530-1.
2006: Krishnan Mani S; O'Brien John T; Firbank Michael J; Pantoni Leonardo; Carlucci Giovanna; Erkinjuntti Timo; Wallin Anders; Wahlund Lars-Olof; Scheltens Philip; van Straaten Elisabeth C W; Inzitari Domenico;
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study.
International journal of geriatric psychiatry 2006;21(10):983-9.
2006: Wessels A M; Simsek S; Remijnse P L; Veltman D J; Biessels G J; Barkhof F; Scheltens P; Snoek F J; Heine R J; Rombouts S A R B
Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy.
Diabetologia 2006;49(10):2474-80.
2006: Gouw A A; Van der Flier W M; van Straaten E C W; Barkhof F; Ferro J M; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund L O; Waldemar G; Schmidt R; Fazekas F; Scheltens Ph;
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.
Journal of neurology 2006;253(9):1189-96.
2006: Damoiseaux J S; Rombouts S A R B; Barkhof F; Scheltens P; Stam C J; Smith S M; Beckmann C F
Consistent resting-state networks across healthy subjects.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(37):13848-53.
2006: Derksen E; Vernooij-Dassen M; Gillissen F; Olde Rikkert M; Scheltens P
Impact of diagnostic disclosure in dementia on patients and carers: qualitative case series analysis.
Aging & mental health 2006;10(5):525-31.
2006: de Leeuw Frank-Erik; Korf Esther; Barkhof Frederik; Scheltens Philip
White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.
Stroke; a journal of cerebral circulation 2006;37(9):2248-52.
2006: Stam C J; Jones B F; Manshanden I; van Cappellen van Walsum A M; Montez T; Verbunt J P A; de Munck J C; van Dijk B W; Berendse H W; Scheltens P
Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease.
NeuroImage 2006;32(3):1335-44.
2006: van der Flier W M; Schoonenboom S N M; Pijnenburg Y A L; Fox N C; Scheltens P
The effect of APOE genotype on clinical phenotype in Alzheimer disease.
Neurology 2006;67(3):526-7.
2006: Bouwman Femke H; van der Flier Wiesje M; Schoonenboom Niki S M; van Elk Evert J; Kok Astrid; Scheltens Philip; Blankenstein Marinus A
Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders.
Clinical chemistry 2006;52(8):1604-6.
2006: Ewers M; Teipel S J; Dietrich O; Schönberg S O; Jessen F; Heun R; Scheltens P; van de Pol L; Freymann N R; Moeller H-J; Hampel H
Multicenter assessment of reliability of cranial MRI.
Neurobiology of aging 2006;27(8):1051-9.
2006: Goekoop Rutger; Barkhof Frederik; Duschek Erik J J; Netelenbos Coen; Knol Dirk L; Scheltens Philip; Rombouts Serge A R B
Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(7):1508-18.
2006: Mijnhout G S; Scheltens P; Diamant M; Biessels G J; Wessels A M; Simsek S; Snoek F J; Heine R J
Diabetic encephalopathy: A concept in need of a definition.
Diabetologia 2006;49(6):1447-8.
2006: Portet F; Ousset P J; Visser P J; Frisoni G B; Nobili F; Scheltens Ph; Vellas B; Touchon J;
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease.
Journal of neurology, neurosurgery, and psychiatry 2006;77(6):714-8.
2006: Cordonnier C; van der Flier W M; Sluimer J D; Leys D; Barkhof F; Scheltens P
Prevalence and severity of microbleeds in a memory clinic setting.
Neurology 2006;66(9):1356-60.
2006: Gauthier Serge; Reisberg Barry; Zaudig Michael; Petersen Ronald C; Ritchie Karen; Broich Karl; Belleville Sylvie; Brodaty Henry; Bennett David; Chertkow Howard; Cummings Jeffrey L; de Leon Mony; Feldman Howard; Ganguli Mary; Hampel Harald; Scheltens Philip; Tierney Mary C; Whitehouse Peter; Winblad Bengt;
Mild cognitive impairment.
Lancet 2006;367(9518):1262-70.
2006: Galimberti Daniela; Schoonenboom Niki; Scheltens Philip; Fenoglio Chiara; Bouwman Femke; Venturelli Eliana; Guidi Ilaria; Blankenstein Marinus A; Bresolin Nereo; Scarpini Elio
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Archives of neurology 2006;63(4):538-43.
2006: van de Pol L A; Hensel A; van der Flier W M; Visser P-J; Pijnenburg Y A L; Barkhof F; Gertz H Josef; Scheltens P
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2006;77(4):439-42.
2006: Biessels Geert Jan; Koffeman Aafke; Scheltens Philip
Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic.
Journal of neurology 2006;253(4):477-82.
2006: Scheltens P; Barkhof F
Structural neuroimaging outcomes in clinical dementia trials, with special reference to disease modifying designs.
The journal of nutrition, health & aging 2006;10(2):123-8; discussion 129-30.
2006: Biessels G J; De Leeuw F-E; Lindeboom J; Barkhof F; Scheltens P
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus.
Journal of neurology, neurosurgery, and psychiatry 2006;77(3):304-7.
2006: van Straaten Elisabeth C W; Fazekas Franz; Rostrup Egill; Scheltens Philip; Schmidt Reinhold; Pantoni Leonardo; Inzitari Domenico; Waldemar Gunhild; Erkinjuntti Timo; Mäntylä Riita; Wahlund Lars-Olof; Barkhof Frederik;
Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.
Stroke; a journal of cerebral circulation 2006;37(3):836-40.
2006: Gootjes Liselotte; Bouma Anke; Van Strien Jan W; Scheltens Philip; Stam Cornelis J
Attention modulates hemispheric differences in functional connectivity: evidence from MEG recordings.
NeuroImage 2006;30(1):245-53.
2006: Wessels Alette M; Rombouts Serge A R B; Simsek Suat; Kuijer Joost P A; Kostense Piet J; Barkhof Frederik; Scheltens Philip; Snoek Frank J; Heine Robert J
Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.
Diabetes 2006;55(2):334-40.
2006: Pijnenburg Y A L; Schoonenboom S N M; Barkhof F; Knol D L; Mulder C; Van Kamp G J; Van Swieten J C; Scheltens P
CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging.
Journal of neurology, neurosurgery, and psychiatry 2006;77(2):246-8.
2006: Barkhof F; Scheltens P
Is the whole brain periventricular?
Journal of neurology, neurosurgery, and psychiatry 2006;77(2):143-4.
2006: van de Pol L A; Hensel A; Barkhof F; Gertz H J; Scheltens P; van der Flier W M
Hippocampal atrophy in Alzheimer disease: age matters.
Neurology 2006;66(2):236-8.
2006: Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Venturelli E; Pijnenburg Y A L; Bresolin N; Scarpini E
Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration.
Neurology 2006;66(1):146-7.
2006: Olde Rikkert Marcel G M; van der Flier Wiesje M; de Leeuw Frank-Erik; Verbeek Marcel; Jansen René W M M; Verhey Frans; Scheltens Philip
Multiple diagnostic tests are needed to assess multiple causes of dementia.
Archives of neurology 2006;63(1):144-6.
2006: Biessels Geert Jan; Staekenborg Salka; Brunner Eric; Brayne Carol; Scheltens Philip
Risk of dementia in diabetes mellitus: a systematic review.
Lancet neurology 2006;5(1):64-74.
2006: Bastos Leite António J; van der Flier Wiesje M; van Straaten Elisabeth C W; Scheltens Philip; Barkhof Frederik
Infratentorial abnormalities in vascular dementia.
Stroke; a journal of cerebral circulation 2006;37(1):105-10.
2006: Goekoop Rutger; Scheltens Philip; Barkhof Frederik; Rombouts Serge A R B
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Brain : a journal of neurology 2006;129(Pt 1):141-57.
2006: Scarpini Elio; Galimberti Daniela; Guidi Ilaria; Bresolin Nereo; Scheltens Philip
Progressive, isolated language disturbance: its significance in a 65-year-old-man. A case report with implications for treatment and review of literature.
Journal of the neurological sciences 2006;240(1-2):45-51.
2006: Semplicini Andrea; Amodio Piero; Leonetti Gastone; Cuspidi Cesare; Umiltà Carlo; Schiff Sami; Scheltens Philip; Barkhof Frederik; Emanueli Costanza; Cagnin Annachiara; Pizzolato Gilberto; Macchini Luisa; Realdi Anna; Royter Vladimir; Bornstein Natan M; Madeddu Paolo
Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research.
Pharmacology & therapeutics 2006;109(1-2):274-83.
2006: Madureira Sofia; Verdelho Ana; Ferro José; Basile Anna-Maria; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Hennerici Michael; O'brien John; Pantoni Leonardo; Salvadori Emilia; Scheltens Philip; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Inzitari Domenico;
Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.
Neuroepidemiology 2006;27(2):101-16.
2006: Scherder Erik; Knol Dirk; van Tol Marie-Jose; van Someren Eus; Deijen Jan-Berend; Swaab Dick; Scheltens Philip
Effects of high-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease: a pilot study.
Dementia and geriatric cognitive disorders 2006;22(4):267-72.
2006: Basile Anna Maria; Pantoni Leonardo; Pracucci Giovanni; Asplund Kjell; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Ferro José M; Hennerici Michael; O'Brien John; Scheltens Philip; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Inzitari Domenico;
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study.
Cerebrovascular diseases (Basel, Switzerland) 2006;21(5-6):315-22.
2006: van Harten B; Laman D M; van Duijn H; Knol D L; Stam C J; Scheltens P; Weinstein H C
The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complex.
Dementia and geriatric cognitive disorders 2006;21(5-6):322-7.
2006: Gootjes L; Bouma A; Van Strien J W; Van Schijndel R; Barkhof F; Scheltens Ph
Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease.
Neuropsychologia 2006;44(2):208-17.
2005: Pijnenburg Y A L; Zeeman-Rebel A; van der Flier W M; Romkes R M; Gillissen F; Jonker C; Scheltens Ph
[Cognitive disorders appearing before the age of 65 in patients of the Alzheimer Centre of the VU Medical Centre: diagnoses and clinical characteristics]
Nederlands tijdschrift voor geneeskunde 2005;149(51):2862-7.
2005: de Leeuw F E; van Norden A G W; van der Flier W M; Olde Rikkert M G M; Scheltens Ph
[Alzheimer's disease and treatment of vascular risk factors]
Nederlands tijdschrift voor geneeskunde 2005;149(51):2844-9.
2005: van der Flier W M; Scheltens P
Use of laboratory and imaging investigations in dementia.
Journal of neurology, neurosurgery, and psychiatry 2005;76 Suppl 5():v45-52.
2005: van der Flier W M; Scheltens P
Epidemiology and risk factors of dementia.
Journal of neurology, neurosurgery, and psychiatry 2005;76 Suppl 5():v2-7.
2005: Rombouts Serge A R B; Barkhof Frederik; Goekoop Rutger; Stam Cornelis J; Scheltens Philip
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study.
Human brain mapping 2005;26(4):231-9.
2005: van der Flier W M; van Straaten E C W; Barkhof F; Ferro J M; Pantoni L; Basile A M; Inzitari D; Erkinjuntti T; Wahlund L O; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study.
Journal of neurology, neurosurgery, and psychiatry 2005;76(11):1497-500.
2005: van der Flier W M; van Straaten E C W; Barkhof F; Scheltens P
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia.
Neurology 2005;65(8):1341.
2005: Lazeron R H C; Boringa J B; Schouten M; Uitdehaag B M J; Bergers E; Lindeboom J; Eikelenboom M I; Scheltens P H; Barkhof F; Polman C H
Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(5):524-31.
2005: Verbeek Marcel M; Pijnenburg Yolande A; Schoonenboom Niki S; Kremer Berry P H; Scheltens Philip
Cerebrospinal fluid tau levels in frontotemporal dementia.
Annals of neurology 2005;58(4):656-7; author reply 657.
2005: Visser P J; Scheltens P; Verhey F R J
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?
Journal of neurology, neurosurgery, and psychiatry 2005;76(10):1348-54.
2005: van der Flier Wiesje M; van Straaten Elizabeth C W; Barkhof Frederik; Verdelho Ana; Madureira Sofia; Pantoni Leonardo; Inzitari Domenico; Erkinjuntti Timo; Crisby Militta; Waldemar Gunhild; Schmidt Reinhold; Fazekas Franz; Scheltens Philip
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.
Stroke; a journal of cerebral circulation 2005;36(10):2116-20.
2005: de Leeuw F-E; Barkhof F; Scheltens P
Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?
Journal of neurology, neurosurgery, and psychiatry 2005;76(9):1286-8.
2005: Mulder Cees; Schoonenboom Niki S M; Jansen Erwin E W; Verhoeven Nanda M; van Kamp Gerard J; Jakobs Cornelis; Scheltens Philip
The transmethylation cycle in the brain of Alzheimer patients.
Neuroscience letters 2005;386(2):69-71.
2005: Schoonenboom Niki S; Mulder Cees; Van Kamp Gerard J; Mehta Sangita P; Scheltens Philip; Blankenstein Marinus A; Mehta Pankaj D
Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?
Annals of neurology 2005;58(1):139-42.
2005: Rombouts Serge A R B; Goekoop Rutger; Stam Cornelis J; Barkhof Frederik; Scheltens Philip
Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease.
NeuroImage 2005;26(4):1078-85.
2005: Derksen Els; Vernooij-Dassen Myrra; Gillissen Freek; Olde-Rikkert Marcel; Scheltens Philip
The impact of diagnostic disclosure in dementia: a qualitative case analysis.
International psychogeriatrics / IPA 2005;17(2):319-26.
2005: de Leeuw Frank-Erik; van der Flier Wiesje M; Scheltens Philip
A 24-year follow-up of body mass index and cerebral atrophy.
Neurology 2005;64(11):1990-1; author reply 1990-1.
2005: Mulder Cees; Scheltens Philip; Barkhof Frederik; Gundy Chad; Verstraeten Rob A; de Leeuw Frank-Erik
Low vitamin B6 levels are associated with white matter lesions in Alzheimer's disease.
Journal of the American Geriatrics Society 2005;53(6):1073-4.
2005: Schoonenboom Niki S M; Mulder Cees; Vanderstichele Hugo; Pijnenburg Yolande A L; Van Kamp Gerard J; Scheltens Philip; Mehta Pankaj D; Blankenstein Marinus A
Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.
Clinical chemistry 2005;51(6):1057-60.
2005: Rombouts Serge; Scheltens Philip
Functional connectivity in elderly controls and AD patients using resting state fMRI: a pilot study.
Current Alzheimer research 2005;2(2):115-6.
2005: Goekoop R; Duschek E J J; Knol D L; Barkhof F; Netelenbos C; Scheltens Ph; Rombouts S A R B
Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior.
NeuroImage 2005;25(1):63-75.
2005: Stam C J; Montez T; Jones B F; Rombouts S A R B; van der Made Y; Pijnenburg Y A L; Scheltens Ph
Disturbed fluctuations of resting state EEG synchronization in Alzheimer's disease.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2005;116(3):708-15.
2005: Schoonenboom S N M; Visser P J; Mulder C; Lindeboom J; Van Elk E J; Van Kamp G J; Scheltens P H
Biomarker profiles and their relation to clinical variables in mild cognitive impairment.
Neurocase : case studies in neuropsychology, neuropsychiatry, and behavioural neurology 2005;11(1):8-13.
2005: van Stegeren Anda H; Goekoop Rutger; Everaerd Walter; Scheltens Philip; Barkhof Frederik; Kuijer Joost P A; Rombouts Serge A R B
Noradrenaline mediates amygdala activation in men and women during encoding of emotional material.
NeuroImage 2005;24(3):898-909.
2005: Meeter Martijn; Kollen Ariane; Scheltens Philip
Retrograde amnesia for semantic information in Alzheimer's disease.
Journal of the International Neuropsychological Society : JINS 2005;11(1):40-8.
2005: Schoonenboom Niki S M; Mulder Cees; Vanderstichele Hugo; Van Elk Evert-Jan; Kok Astrid; Van Kamp Gerard J; Scheltens Philip; Blankenstein Marinus A
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.
Clinical chemistry 2005;51(1):189-95.
2005: Korf Esther S C; Scheltens Philip; Barkhof Frederik; de Leeuw Frank-Erik
Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
Dementia and geriatric cognitive disorders 2005;20(6):331-7.
2005: Wiltfang J; Lewczuk P; Riederer P; Grünblatt E; Hock C; Scheltens P; Hampel H; Vanderstichele H; Iqbal K; Galasko D; Lannfelt L; Otto M; Esselmann H; Henkel A W; Kornhuber J; Blennow K
Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(2):69-84.
2005: van Dijk Koene R A; Scheltens Philip; Luijpen Marijn W; Sergeant Joseph A; Scherder Erik J A
Peripheral electrical stimulation in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2005;19(5-6):361-8.
2005: Visser Pieter Jelle; Scheltens Philip; Pelgrim Esther; Verhey Frans R J;
Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.
Dementia and geriatric cognitive disorders 2005;19(2-3):126-33.
2005: Pantoni Leonardo; Basile Anna Maria; Pracucci Giovanni; Asplund Kjell; Bogousslavsky Julien; Chabriat Hugues; Erkinjuntti Timo; Fazekas Franz; Ferro José M; Hennerici Michael; O'brien John; Scheltens Philip; Visser Marieke C; Wahlund Lars-Olof; Waldemar Gunhild; Wallin Anders; Inzitari Domenico
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology.
Neuroepidemiology 2005;24(1-2):51-62.
2004: Bastos Leite António J; Scheltens Philip; Barkhof Frederik
Pathological aging of the brain: an overview.
Topics in magnetic resonance imaging : TMRI 2004;15(6):369-89.
2004: Goekoop Rutger; Rombouts Serge A R B; Jonker Cees; Hibbel Anneke; Knol Dirk L; Truyen Luc; Barkhof Frederik; Scheltens Philip
Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study.
NeuroImage 2004;23(4):1450-9.
2004: van Straaten E C W; Scheltens Ph; Barkhof F
MRI and CT in the diagnosis of vascular dementia.
Journal of the neurological sciences 2004;226(1-2):9-12.
2004: Karas G B; Scheltens P; Rombouts S A R B; Visser P J; van Schijndel R A; Fox N C; Barkhof F
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.
NeuroImage 2004;23(2):708-16.
2004: Lazeron Richard H C; Rombouts Serge A R B; Scheltens Philip; Polman Chris H; Barkhof Frederik
An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(5):549-55.
2004: Hack C E; Scheltens P
Intravenous immunoglobulins: a treatment for Alzheimer's disease?
Journal of neurology, neurosurgery, and psychiatry 2004;75(10):1374-5.
2004: De Leeuw F-E; Barkhof F; Scheltens P
Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure.
Journal of neurology, neurosurgery, and psychiatry 2004;75(9):1270-4.
2004: Nestor Peter J; Scheltens Philip; Hodges John R
Advances in the early detection of Alzheimer's disease.
Nature medicine 2004;10 Suppl():S34-41.
2004: Schmidt R; Scheltens Ph; Erkinjuntti T; Pantoni L; Markus H S; Wallin A; Barkhof F; Fazekas F
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease.
Neurology 2004;63(1):139-44.
2004: Korf Esther S C; Wahlund Lars-Olof; Visser Pieter Jelle; Scheltens Philip
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.
Neurology 2004;63(1):94-100.
2004: Kenny R A; Shaw F E; O'Brien J T; Scheltens P H; Kalaria R; Ballard C
Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions.
Journal of neurology, neurosurgery, and psychiatry 2004;75(7):966-71.
2004: Teunissen Charlotte E; Scheltens Philip
Biomarkers for Alzheimer's disease. Which way to go?
Neurobiology of aging 2004;25(6):695-6.
2004: Korf Esther S C; White Lon R; Scheltens Philip; Launer Lenore J
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study.
Hypertension 2004;44(1):29-34.
2004: Peters M J V; Ponds R W H M; van den Ham P; Scheltens Ph; Verhey F R J
[Detection of dementia of the Alzheimer type with the 7 Minutes Test (7 MT)]
Tijdschrift voor gerontologie en geriatrie 2004;35(3):114-20.
2004: Pijnenburg Y A L; v d Made Y; van Cappellen van Walsum A M; Knol D L; Scheltens Ph; Stam C J
EEG synchronization likelihood in mild cognitive impairment and Alzheimer's disease during a working memory task.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2004;115(6):1332-9.
2004: Pijnenburg Y A L; Schoonenboom N S M; Rosso S M; Mulder C; Van Kamp G J; Van Swieten J C; Scheltens P
CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration.
Neurology 2004;62(9):1649.
2004: Schoonenboom N S M; Pijnenburg Y A L; Mulder C; Rosso S M; Van Elk E-J; Van Kamp G J; Van Swieten J C; Scheltens Ph
Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.
Neurology 2004;62(9):1580-4.
2004: Prins N D; van Straaten E C W; van Dijk E J; Simoni M; van Schijndel R A; Vrooman H A; Koudstaal P J; Scheltens P; Breteler M M B; Barkhof F
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics.
Neurology 2004;62(9):1533-9.
2004: Meulen E F J; Schmand B; van Campen J P; de Koning S J; Ponds R W; Scheltens P; Verhey F R
The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia.
Journal of neurology, neurosurgery, and psychiatry 2004;75(5):700-5.
2004: Feldman H; Scheltens P; Scarpini E; Hermann N; Mesenbrink P; Mancione L; Tekin S; Lane R; Ferris S
Behavioral symptoms in mild cognitive impairment.
Neurology 2004;62(7):1199-201.
2004: van de Pol L; Scheltens P
Grey hair and grey matter.
Journal of neurology, neurosurgery, and psychiatry 2004;75(4):527-8.
2004: Bastos Leite António J; van Straaten Elisabeth C W; Scheltens Philip; Lycklama Geert; Barkhof Frederik
Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.
Stroke; a journal of cerebral circulation 2004;35(2):415-9.
2004: Rikkert Marcel G; Dekkers Wim J; Scheltens Philip; Verhey Frans
Memantine in moderate-to-severe Alzheimer disease evidence and ethics based?
Alzheimer disease and associated disorders 2004;18(1):47-8; author reply 48.
2004: de Leeuw Frank-Erik; Barkhof Frederik; Scheltens Philip
White matter lesions and hippocampal atrophy in Alzheimer's disease.
Neurology 2004;62(2):310-2.
2004: Vandenbroucke M W G; Goekoop R; Duschek E J J; Netelenbos J C; Kuijer J P A; Barkhof F; Scheltens Ph; Rombouts S A R B
Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI.
NeuroImage 2004;21(1):173-80.
2004: Gootjes L; Teipel S J; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller H-J; Hampel H
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Dementia and geriatric cognitive disorders 2004;18(2):180-8.
2004: Pijnenburg Yolande A L; Gillissen Freek; Jonker Cees; Scheltens Philip
Initial complaints in frontotemporal lobar degeneration.
Dementia and geriatric cognitive disorders 2004;17(4):302-6.
2004: van Harten Barbera; Courant Marise N J; Scheltens Philip; Weinstein Henry C
Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalus.
Dementia and geriatric cognitive disorders 2004;18(1):109-14.
2003: Frisoni G B; Scheltens P h; Galluzzi S; Nobili F M; Fox N C; Robert P H; Soininen H; Wahlund L-O; Waldemar G; Salmon E
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC.
Journal of neurology, neurosurgery, and psychiatry 2003;74(10):1371-81.
2003: Rombouts S A R B; Stam C J; Kuijer J P A; Scheltens Ph; Barkhof F
Identifying confounds to increase specificity during a "no task condition". Evidence for hippocampal connectivity using fMRI.
NeuroImage 2003;20(2):1236-45.
2003: Rosso Sonia M; van Herpen Esther; Pijnenburg Yolande A L; Schoonenboom Niki S M; Scheltens Philip; Heutink Peter; van Swieten John C
Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.
Archives of neurology 2003;60(9):1209-13.
2003: Scarpini Elio; Scheltens Philip; Feldman Howard
Treatment of Alzheimer's disease: current status and new perspectives.
Lancet neurology 2003;2(9):539-47.
2003: Rosso Sonia M; Donker Kaat Laura; Baks Timo; Joosse Marijke; de Koning Inge; Pijnenburg Yolande; de Jong Daniëlle; Dooijes Dennis; Kamphorst Wouter; Ravid Rivka; Niermeijer Martinus F; Verheij Frans; Kremer H P; Scheltens Philip; van Duijn Cornelia M; Heutink Peter; van Swieten John C
Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.
Brain : a journal of neurology 2003;126(Pt 9):2016-22.
2003: Lazeron Richard H C; Rombouts Serge A R B; de Sonneville Leo; Barkhof Frederik; Scheltens Philip
A paced visual serial addition test for fMRI.
Journal of the neurological sciences 2003;213(1-2):29-34.
2003: Mulder C; Wahlund L-O; Teerlink T; Blomberg M; Veerhuis R; van Kamp G J; Scheltens P; Scheffer P G
Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(8):949-55.
2003: Stam C J; van der Made Y; Pijnenburg Y A L; Scheltens Ph
EEG synchronization in mild cognitive impairment and Alzheimer's disease.
Acta neurologica Scandinavica 2003;108(2):90-6.
2003: van Straaten Elisabeth C W; Scheltens Philip; Knol Dirk L; van Buchem Mark A; van Dijk Ewout J; Hofman Paul A M; Karas Giorgos; Kjartansson Olafur; de Leeuw Frank-Erik; Prins Niels D; Schmidt Reinhold; Visser Marieke C; Weinstein Henry C; Barkhof Frederik
Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study.
Stroke; a journal of cerebral circulation 2003;34(8):1907-12.
2003: Rombouts S A R B; van Swieten J C; Pijnenburg Y A L; Goekoop R; Barkhof F; Scheltens P
Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD.
Neurology 2003;60(12):1904-8.
2003: van Cappellen van Walsum A-M; Pijnenburg Y A L; Berendse H W; van Dijk B W; Knol D L; Scheltens Ph; Stam C J
A neural complexity measure applied to MEG data in Alzheimer's disease.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2003;114(6):1034-40.
2003: Karas G B; Burton E J; Rombouts S A R B; van Schijndel R A; O'Brien J T; Scheltens P h; McKeith I G; Williams D; Ballard C; Barkhof F
A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry.
NeuroImage 2003;18(4):895-907.
2003: Galimberti Daniela; Schoonenboom Niki; Scarpini Elio; Scheltens Philip;
Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients.
Annals of neurology 2003;53(4):547-8.
2003: Kapeller P; Barber R; Vermeulen R J; Adèr H; Scheltens P; Freidl W; Almkvist O; Moretti M; del Ser T; Vaghfeldt P; Enzinger C; Barkhof F; Inzitari D; Erkinjunti T; Schmidt R; Fazekas F;
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements.
Stroke; a journal of cerebral circulation 2003;34(2):441-5.
2003: Pijnenburg Yolande A L; Schoonenboom Niki S N M; Scheltens Philip
Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.
Neurology 2003;60(2):353-4; author reply 353-4.
2003: Scheltens Philip; Barkhof Frederik; Fazekas Franz
White-matter changes on MRI as surrogate marker.
International psychogeriatrics / IPA 2003;15 Suppl 1():261-5.
2003: Van der Werf Ysbrand D; Scheltens Philip; Lindeboom Jaap; Witter Menno P; Uylings Harry B M; Jolles Jelle
Deficits of memory, executive functioning and attention following infarction in the thalamus; a study of 22 cases with localised lesions.
Neuropsychologia 2003;41(10):1330-44.
2002: Stam Cornelis J; van Cappellen van Walsum Anne Marie; Pijnenburg Yolande A L; Berendse Henk W; de Munck Jan C; Scheltens Philip; van Dijk Bob W
Generalized synchronization of MEG recordings in Alzheimer's Disease: evidence for involvement of the gamma band.
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2002;19(6):562-74.
2002: Mulder C; Schoonenboom S N M; Wahlund L-O; Scheltens Ph; van Kamp G J; Veerhuis R; Hack C E; Blomberg M; Schutgens R B H; Eikelenboom P
CSF markers related to pathogenetic mechanisms in Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(12):1491-8.
2002: Rombouts S A R B; Barkhof F; Van Meel C S; Scheltens P
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2002;73(6):665-71.
2002: Burton E J; Karas G; Paling S M; Barber R; Williams E D; Ballard C G; McKeith I G; Scheltens P; Barkhof F; O'Brien J T
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.
NeuroImage 2002;17(2):618-30.
2002: Mulder C; Wahlund L-O; Blomberg M; de Jong S; van Kamp G J; Scheltens P; Teerlink T
Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(9):1203-8.
2002: Nandoe Rishi D S; Scheltens Philip; Eikelenboom Piet
Head trauma and Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2002;4(4):303-8.
2002: Postma T J; Klein M; Verstappen C C P; Bromberg J E C; Swennen M; Langendijk J A; Taphoorn M J B; Scheltens P; Slotman B J; van der Ploeg H M; Aaronson N K; Heimans J J
Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma.
Neurology 2002;59(1):121-3.
2002: Scheltens Philip; Fox Nick; Barkhof Frederik; De Carli Charles
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.
Lancet neurology 2002;1(1):13-21.
2002: Visser P J; Verhey F R J; Hofman P A M; Scheltens P; Jolles J
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
Journal of neurology, neurosurgery, and psychiatry 2002;72(4):491-7.
2002: Visser Pieter Jelle; Verhey Frans R J; Scheltens Philip; Cruts Marc; Ponds Rudolf W H M; Van Broeckhoven Christine L; Jolles Jellemer
Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.
Journal of neurology 2002;249(3):312-9.
2002: Bokde A L W; Teipel S J; Zebuhr Y; Leinsinger G; Gootjes L; Schwarz R; Buerger K; Scheltens P; Moeller H-J; Hampel H
A new rapid landmark-based regional MRI segmentation method of the brain.
Journal of the neurological sciences 2002;194(1):35-40.
2002: Weinstein H C; van Harten B; Scheltens P
[Cerebral white matter lesions in the elderly: vascular risk factors and cognitive consequences]
Nederlands tijdschrift voor geneeskunde 2002;146(3):140-1.
2002: van Dijk Koene R A; Scherder Erik J A; Scheltens Philip; Sergeant Joseph A
Effects of transcutaneous electrical nerve stimulation (TENS) on non-pain related cognitive and behavioural functioning.
Reviews in the neurosciences 2002;13(3):257-70.
2002: Fazekas Franz; Barkhof F; Wahlund L O; Pantoni L; Erkinjuntti T; Scheltens P; Schmidt R
CT and MRI rating of white matter lesions.
Cerebrovascular diseases (Basel, Switzerland) 2002;13 Suppl 2():31-6.
2002: Barkhof Frederik; Scheltens Philip
Imaging of white matter lesions.
Cerebrovascular diseases (Basel, Switzerland) 2002;13 Suppl 2():21-30.
2001: Van Gool W A; Weinstein H C; Scheltens P; Walstra G J;
Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study.
Lancet 2001;358(9280):455-60.
2001: Head M W; Tissingh G; Uitdehaag B M; Barkhof F; Bunn T J; Ironside J W; Kamphorst W; Scheltens P
Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype.
Annals of neurology 2001;50(2):258-61.
2001: Rombouts S A; Barkhof F; Witter M P; Machielsen W C; Scheltens P
Anterior medial temporal lobe activation during attempted retrieval of encoded visuospatial scenes: an event-related fMRI study.
NeuroImage 2001;14(1 Pt 1):67-76.
2001: Sie LTL; Rombouts S A; Valk I J; Hart A A; Scheltens P; van der Knaap M S
Functional MRI of visual cortex in sedated 18 month-old infants with or without periventricular leukomalacia.
Developmental medicine and child neurology 2001;43(7):486-90.
2001: Scheltens P H
Structural neuroimaging of Alzheimer's disease and other dementias.
Aging (Milan, Italy) 2001;13(3):203-9.
2001: Wahlund L O; Barkhof F; Fazekas F; Bronge L; Augustin M; Sjögren M; Wallin A; Ader H; Leys D; Pantoni L; Pasquier F; Erkinjuntti T; Scheltens P;
A new rating scale for age-related white matter changes applicable to MRI and CT.
Stroke; a journal of cerebral circulation 2001;32(6):1318-22.
2001: Neele S J; Rombouts S A; Bierlaagh M A; Barkhof F; Scheltens P; Netelenbos J C
Raloxifene affects brain activation patterns in postmenopausal women during visual encoding.
The Journal of clinical endocrinology and metabolism 2001;86(3):1422-4.
2001: Galton C J; Gomez-Anson B; Antoun N; Scheltens P; Patterson K; Graves M; Sahakian B J; Hodges J R
Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia.
Journal of neurology, neurosurgery, and psychiatry 2001;70(2):165-73.
2000: Rombouts S A; Barkhof F; Veltman D J; Machielsen W C; Witter M P; Bierlaagh M A; Lazeron R H; Valk J; Scheltens P
Functional MR imaging in Alzheimer's disease during memory encoding.
AJNR. American journal of neuroradiology 2000;21(10):1869-75.
2000: Wahlund L O; Julin P; Johansson S E; Scheltens P
Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study.
Journal of neurology, neurosurgery, and psychiatry 2000;69(5):630-5.
2000: Barber R; Gholkar A; Scheltens P; Ballard C; McKeith I G; O'Brien J T
MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease.
International journal of geriatric psychiatry 2000;15(10):911-6.
2000: Mulder C; Scheltens P; Visser J J; van Kamp G J; Schutgens R B
Genetic and biochemical markers for Alzheimer's disease: recent developments.
Annals of clinical biochemistry 2000;37 ( Pt 5)():593-607.
2000: Lazeron R H; Rombouts S A; Machielsen W C; Scheltens P; Witter M P; Uylings H B; Barkhof F
Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging.
AJNR. American journal of neuroradiology 2000;21(8):1407-14.
2000: Scheltens P; Korf E S
Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
Current opinion in neurology 2000;13(4):391-6.
2000: Rombouts S A; Barkhof F; Witter M P; Scheltens P
Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease.
Neuroscience letters 2000;285(3):231-3.
2000: Scheltens P; Kittner B
Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;903():542-6.
2000: Ballard C; O'Brien J; Barber B; Scheltens P; Shaw F; McKeith I; Kenny R A
Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia.
Annals of the New York Academy of Sciences 2000;903():442-5.
2000: Erkinjuntti T; Inzitari D; Pantoni L; Wallin A; Scheltens P; Rockwood K; Desmond D W
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?
Annals of the New York Academy of Sciences 2000;903():262-72.
2000: Berendse H W; Verbunt J P; Scheltens P; van Dijk B W; Jonkman E J
Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2000;111(4):604-12.
2000: Waldemar G; Dubois B; Emre M; Scheltens P; Tariska P; Rossor M
Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7(2):133-44.
2000: Machielsen W C; Rombouts S A; Barkhof F; Scheltens P; Witter M P
FMRI of visual encoding: reproducibility of activation.
Human brain mapping 2000;9(3):156-64.
2000: Witter M P; Naber P A; van Haeften T; Machielsen W C; Rombouts S A; Barkhof F; Scheltens P; Lopes da Silva F H
Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways.
Hippocampus 2000;10(4):398-410.
2000: Erkinjuntti T; Inzitari D; Pantoni L; Wallin A; Scheltens P; Rockwood K; Roman G C; Chui H; Desmond D W
Research criteria for subcortical vascular dementia in clinical trials.
Journal of neural transmission. Supplementum 2000;59():23-30.
2000: Kuiper M A; Teerlink T; Visser J J; Bergmans P L; Scheltens P; Wolters E C
L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(2):183-9.
1999: Erkinjuntti T; Bowler J V; DeCarli C S; Fazekas F; Inzitari D; O'Brien J T; Pantoni L; Rockwood K; Scheltens P; Wahlund L O; Desmond D W
Imaging of static brain lesions in vascular dementia: implications for clinical trials.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S81-90.
1999: Pantoni L; Leys D; Fazekas F; Longstreth W T; Inzitari D; Wallin A; Filippi M; Scheltens P; Erkinjuntti T; Hachinski V
Role of white matter lesions in cognitive impairment of vascular origin.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S49-54.
1999: Leys D; Erkinjuntti T; Desmond D W; Schmidt R; Englund E; Pasquier F; Parnetti L; Ghika J; Kalaria R N; Chabriat H; Scheltens P; Bogousslavsky J
Vascular dementia: the role of cerebral infarcts.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S38-48.
1999: Konings C H; Kuiper M A; Teerlink T; Mulder C; Scheltens P; Wolters E C
Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophy.
Journal of the neurological sciences 1999;168(2):112-5.
1999: Barber R; Gholkar A; Scheltens P; Ballard C; McKeith I G; Morris C M; O'Brien J T
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Archives of neurology 1999;56(8):961-5.
1999: Barber R; Scheltens P; Gholkar A; Ballard C; McKeith I; Ince P; Perry R; O'Brien J
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.
Journal of neurology, neurosurgery, and psychiatry 1999;67(1):66-72.
1999: Wahlund L O; Julin P; Lindqvist J; Scheltens P
Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry.
Psychiatry research 1999;90(3):193-9.
1999: Visser P J; Scheltens P; Verhey F R; Schmand B; Launer L J; Jolles J; Jonker C
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.
Journal of neurology 1999;246(6):477-85.
1999: Claus J J; Strijers R L; Jonkman E J; Ongerboer de Visser B W; Jonker C; Walstra G J; Scheltens P; van Gool W A
The diagnostic value of electroencephalography in mild senile Alzheimer's disease.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 1999;110(5):825-32.
1999: Barber R; Gholkar A; Scheltens P; Ballard C; McKeith I G; O'Brien J T
Medial temporal lobe atrophy on MRI in dementia with Lewy bodies.
Neurology 1999;52(6):1153-8.
1999: Harvey G T; Hughes J; McKeith I G; Briel R; Ballard C; Gholkar A; Scheltens P; Perry R H; Ince P; O'Brien J T
Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study.
Psychological medicine 1999;29(1):181-7.
1999: Scheltens P
Early diagnosis of dementia: neuroimaging.
Journal of neurology 1999;246(1):16-20.
1999: Van Der Werf Y D; Weerts J G; Jolles J; Witter M P; Lindeboom J; Scheltens P
Neuropsychological correlates of a right unilateral lacunar thalamic infarction.
Journal of neurology, neurosurgery, and psychiatry 1999;66(1):36-42.
1999: Rombouts S A; Scheltens P; Machielson W C; Barkhof F; Hoogenraad F G; Veltman D J; Valk J; Witter M P
Parametric fMRI analysis of visual encoding in the human medial temporal lobe.
Hippocampus 1999;9(6):637-43.
1998: Soininen H S; Scheltens P
Early diagnostic indices for the prevention of Alzheimer's disease.
Annals of medicine 1998;30(6):553-9.
1998: Verhey F R; Scheltens P
[Drugs for Alzheimer disease: what will the minister decide]
Tijdschrift voor gerontologie en geriatrie 1998;29(6):278-9.
1998: Verhey F R; Heeren T J; Scheltens P; van Gool W A
[Cholinesterase inhibitors for Alzheimer disease: preliminary recommendations for treatment. Dutch Society for Psychiatry, Section of Geriatric Psychiatry]
Nederlands tijdschrift voor geneeskunde 1998;142(38):2091-6.
1998: Erkinjuntti T; Pantoni L; Scheltens P
Cooperation and networking on white matter disorders: the European Task Force on Age-Related White Matter Changes.
Dementia and geriatric cognitive disorders 1998;9 Suppl 1():44-5.
1998: Fazekas F; Schmidt R; Scheltens P
Pathophysiologic mechanisms in the development of age-related white matter changes of the brain.
Dementia and geriatric cognitive disorders 1998;9 Suppl 1():2-5.
1998: Veldink J H; Scheltens P; Jonker C; Launer L J
Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure.
Neurology 1998;51(1):319-20.
1998: Rombouts S A; Lazeron R H; Scheltens P; Uitdehaag B M; Sprenger M; Valk J; Barkhof F
Visual activation patterns in patients with optic neuritis: an fMRI pilot study.
Neurology 1998;50(6):1896-9.
1998: Stevens M; van Duijn C M; Kamphorst W; de Knijff P; Heutink P; van Gool W A; Scheltens P; Ravid R; Oostra B A; Niermeijer M F; van Swieten J C
Familial aggregation in frontotemporal dementia.
Neurology 1998;50(6):1541-5.
1998: Scheltens P; Hijdra A H
Diagnostic criteria for vascular dementia.
Haemostasis 1998;28(3-4):151-7.
1998: van Walderveen M A; Kamphorst W; Scheltens P; van Waesberghe J H; Ravid R; Valk J; Polman C H; Barkhof F
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis.
Neurology 1998;50(5):1282-8.
1998: Nijeholt G J; van Walderveen M A; Castelijns J A; van Waesberghe J H; Polman C; Scheltens P; Rosier P F; Jongen P J; Barkhof F
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
Brain : a journal of neurology 1998;121 ( Pt 4)():687-97.
1998: van Waesberghe J H; van Walderveen M A; Castelijns J A; Scheltens P; Lycklama à Nijeholt G J; Polman C H; Barkhof F
Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.
AJNR. American journal of neuroradiology 1998;19(4):675-83.
1998: Pasquier F; Leys D; Scheltens P
The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease.
Journal of neural transmission. Supplementum 1998;54():117-27.
1998: Scheltens P; Erkinjunti T; Leys D; Wahlund L O; Inzitari D; del Ser T; Pasquier F; Barkhof F; Mäntylä R; Bowler J; Wallin A; Ghika J; Fazekas F; Pantoni L
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes.
European neurology 1998;39(2):80-9.
1998: Rombouts S A; Barkhof F; Hoogenraad F G; Sprenger M; Scheltens P
Within-subject reproducibility of visual activation patterns with functional magnetic resonance imaging using multislice echo planar imaging.
Magnetic resonance imaging 1998;16(2):105-13.
1997: Barkhof F; Filippi M; Miller D H; Scheltens P; Campi A; Polman C H; Comi G; Adèr H J; Losseff N; Valk J
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
Brain : a journal of neurology 1997;120 ( Pt 11)():2059-69.
1997: Rombouts S A; Barkhof F; Hoogenraad F G; Sprenger M; Valk J; Scheltens P
Test-retest analysis with functional MR of the activated area in the human visual cortex.
AJNR. American journal of neuroradiology 1997;18(7):1317-22.
1997: Scheltens P; Launer L J; Barkhof F; Weinstein H C; Jonker C
The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
Alzheimer disease and associated disorders 1997;11(2):63-70.
1997: Lycklama à Nijeholt G J; Barkhof F; Scheltens P; Castelijns J A; Adèr H; van Waesberghe J H; Polman C; Jongen S J; Valk J
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability.
AJNR. American journal of neuroradiology 1997;18(6):1041-8.
1997: Bruyn R P; van Veen M M; Kremer H; Scheltens P H; Padberg G W
Familial spastic paraplegia: evidence for a fourth locus.
Clinical neurology and neurosurgery 1997;99(2):87-90.
1997: Strijers R L; Scheltens P; Jonkman E J; de Rijke W; Hooijer C; Jonker C
Diagnosing Alzheimer's disease in community-dwelling elderly: a comparison of EEG and MRI.
Dementia and geriatric cognitive disorders 1997;8(3):198-202.
1997: Rombouts S A; Machielsen W C; Witter M P; Barkhof F; Lindeboom J; Scheltens P
Visual association encoding activates the medial temporal lobe: a functional magnetic resonance imaging study.
Hippocampus 1997;7(6):594-601.
1997: Scheltens P; van Gool W A
Emerging treatments in dementia.
European neurology 1997;38(3):184-9.
1997: Bodick N; Forette F; Hadler D; Harvey R J; Leber P; McKeith I G; Riekkinen P J; Rossor M N; Scheltens P; Shimohama S; Spiegel R; Tanaka S; Thal L J; Urata Y; Whitehouse P; Wilcock G
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
Alzheimer disease and associated disorders 1997;11 Suppl 3():50-3.
1997: Antuono P; Doody R; Gilman S; Huff J; Scheltens P; Ueda K; Khachaturian Z S
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():22-5.
1997: Bissessur S; Tissingh G; Wolters E C; Scheltens P
rCBF SPECT in Parkinson's disease patients with mental dysfunction.
Journal of neural transmission. Supplementum 1997;50():25-30.
1997: van Waesberghe J H; Castelijns J A; Scheltens P; Truyen L; Lycklana A Nijeholt G J; Hoogenraad F G; Polman C H; Valk J; Barkhof F
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions.
Magnetic resonance imaging 1997;15(2):155-62.
1997: Scheltens P; Pasquier F; Weerts J G; Barkhof F; Leys D
Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging.
European neurology 1997;37(2):95-9.
1996: Rombouts S A; Barkhof F; Sprenger M; Valk J; Scheltens P
The functional basis of ocular dominance: functional MRI (fMRI) findings.
Neuroscience letters 1996;221(1):1-4.
1996: van Someren E J; Hagebeuk E E; Lijzenga C; Scheltens P; de Rooij S E; Jonker C; Pot A M; Mirmiran M; Swaab D F
Circadian rest-activity rhythm disturbances in Alzheimer's disease.
Biological psychiatry 1996;40(4):259-70.
1996: Pasquier F; Leys D; Weerts J G; Mounier-Vehier F; Barkhof F; Scheltens P
Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts.
European neurology 1996;36(5):268-72.
1995: Wielaard R; Bornebroek M; Ophoff R A; Winter-Warnars H A; Scheltens P; Frants R R; Ferrari M D; Haan J
A four-generation Dutch family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), linked to chromosome 19p13.
Clinical neurology and neurosurgery 1995;97(4):307-13.
1995: Scheltens P; Launer L J; Barkhof F; Weinstein H C; van Gool W A
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability.
Journal of neurology 1995;242(9):557-60.
1995: Konings C H; Scheltens P; Kuiper M A; Wolters E C
No evidence for abnormalities in kinetics of platelet monoamine oxidase in Alzheimer's disease.
Clinica chimica acta; international journal of clinical chemistry 1995;240(1):99-102.
1995: Scheltens P; Barkhof F; Leys D; Wolters E C; Ravid R; Kamphorst W
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging.
Neurology 1995;45(5):883-8.
1995: Launer L J; Scheltens P; Lindeboom J; Barkhof F; Weinstein H C; Jonker C
Medial temporal lobe atrophy in an open population of very old persons: cognitive, brain atrophy, and sociomedical correlates.
Neurology 1995;45(4):747-52.
1995: Leys D; Scheltens P; Vermersch P; Pruvo J P
[Morphological imaging in the diagnosis of dementia. II. Vascular dementia]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(3):195-200.
1994: Konings C H; Scheltens P; Kuiper M A; Mulder C; Calliauw J; Wolters E C
Cerebrospinal fluid acetylcholinesterase homospecific activity in patients with "probable Alzheimer's disease".
Biological psychiatry 1994;36(10):708-9.
1994: Bruyn R P; van Dijk J G; Scheltens P; Boezeman E H; Ongerboer de Visser B W
Clinically silent dysfunction of dorsal columns and dorsal spinocerebellar tracts in hereditary spastic paraparesis.
Journal of the neurological sciences 1994;125(2):206-11.
1994: Vermersch P; Leys D; Scheltens P; Barkhof F
Visual rating of hippocampal atrophy: correlation with volumetry.
Journal of neurology, neurosurgery, and psychiatry 1994;57(8):1015.
1994: Barkhof F; Tas M W; Frequin S T; Scheltens P; Hommes O R; Nauta J J; Valk J
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.
Neuroradiology 1994;36(5):382-7.
1994: Scheltens P; Leys D; Barkhof F; Vermersch P; Steinling M; Weinstein H C; Pruvo J P; Petit H
[Contribution of morphological imaging in the diagnosis of dementia. I--Alzheimer disease]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1994;15(6):415-22.
1994: Boerman R H; Scheltens P; Weinstein H C
Clinical neurophysiology in the diagnosis of Alzheimer's disease.
Clinical neurology and neurosurgery 1994;96(2):111-8.
1994: Barkhof F; Kouwenhoven M; Scheltens P; Sprenger M; Algra P; Valk J
Phase-contrast cine MR imaging of normal aqueductal CSF flow. Effect of aging and relation to CSF void on modulus MR.
Acta radiologica (Stockholm, Sweden : 1987) 1994;35(2):123-30.
1994: Scheltens P; Ravid R; Kamphorst W
Pathologic findings in a case of primary progressive aphasia.
Neurology 1994;44(2):279-82.
1994: Kuiper M A; Visser J J; Bergmans P L; Scheltens P; Wolters E C
Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients.
Journal of the neurological sciences 1994;121(1):46-9.
1994: Vermersch P; Scheltens P; Barkhof F; Steinling M; Leys D
Evidence for atrophy of the corpus callosum in Alzheimer's disease.
European neurology 1994;34(2):83-6.
1994: Kuiper M A; Mulder C; van Kamp G J; Scheltens P; Wolters E C
Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy.
Journal of neural transmission. Parkinson's disease and dementia section 1994;7(2):109-14.
1993: Torenbeek R; Scheltens P; Strack van Schijindel R J; Algra P R; Heimans J J; van der Valk P
Angiotropic intravascular large-cell lymphoma with massive cerebral extension.
Journal of neurology, neurosurgery, and psychiatry 1993;56(8):914-6.
1993: Torreman M; Smit L M; van der Valk P; Valk J; Scheltens P
A case of macrocephaly, hydrocephalus, megacerebellum, white matter abnormalities and Rosenthal fibres.
Developmental medicine and child neurology 1993;35(8):732-6.
1993: Konings C H; Kuiper M A; Scheltens P; Grijpma A M; van Pelt W; Wolters E C
Re-evaluation of cerebrospinal fluid angiotensin-converting enzyme activity in patients with 'probable' Alzheimer's disease.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(8):495-7.
1993: Barkhof F; Scheltens P; Kamphorst W
Pre-and post-mortem MR imaging of unsuspected multiple sclerosis in a patient with Alzheimer's disease.
Journal of the neurological sciences 1993;117(1-2):175-8.
1993: Bruyn R P; Scheltens P; Lycklama à Nijeholt J; de Jong J M
Autosomal recessive paraparesis with amyotrophy of the hands and feet.
Acta neurologica Scandinavica 1993;87(6):443-5.
1993: Weinstein H C; Scheltens P; Hijdra A; van Royen E A
Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.
Clinical neurology and neurosurgery 1993;95(2):81-91.
1993: de Waal R; Algra P R; Heimans J J; Wolbers J G; Scheltens P
Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device.
Journal of neuro-oncology 1993;15(3):269-73.
1993: Scheltens P; Barkhof F; Leys D; Pruvo J P; Nauta J J; Vermersch P; Steinling M; Valk J
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging.
Journal of the neurological sciences 1993;114(1):7-12.
1993: Scheltens P; Vermersch P; Leys D
[Heterogeneity of Alzheimer's disease]
Revue neurologique 1993;149(1):14-25.
1993: Bruyn R P; Hageman G; Geelen J A; van der Weel F A; Rozeboom A R; Barkhof F; Scheltens P
SPECT, CT and MRI in a Turkish family with Huntington's disease.
Neuroradiology 1993;35(7):525-8.
1993: Kuiper M A; van Kamp G J; Bergmans P L; Scheltens P; Wolters E C
Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1993;6(2):145-9.
1992: Smits R C; Polder T W; Ponssen H; Scheltens P
[Acute subdural hematoma following minor head injury]
Nederlands tijdschrift voor geneeskunde 1992;136(49):2436-7.
1992: Scheltens P; Weinstein H C; van Gool W A
[The value of new diagnostic techniques in Alzheimer's disease]
Nederlands tijdschrift voor geneeskunde 1992;136(50):2459-62.
1992: Godefroy O; Rousseaux M; Leys D; Destée A; Scheltens P; Pruvo J P
Frontal lobe dysfunction in unilateral lenticulostriate infarcts. Prominent role of cortical lesions.
Archives of neurology 1992;49(12):1285-9.
1992: Barkhof F; Scheltens P; Frequin S T; Nauta J J; Tas M W; Valk J; Hommes O R
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
AJR. American journal of roentgenology 1992;159(5):1041-7.
1992: Kuiper M A; Weinstein H C; Bergmans P L; Scheltens P; Wolters E C
(99mTc)-HM-PAO SPECT and dementia in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(10):981.
1992: Scheltens P; Leys D; Barkhof F; Huglo D; Weinstein H C; Vermersch P; Kuiper M; Steinling M; Wolters E C; Valk J
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
Journal of neurology, neurosurgery, and psychiatry 1992;55(10):967-72.
1992: Uitdehaag B M; Scheltens P; Bertelsmann F W; Bruyn R P
Intracerebral haemorrhage in Sneddon's syndrome.
Journal of the neurological sciences 1992;111(2):227-8.
1992: Barkhof F; Valk J; Hommes O R; Scheltens P; Nauta J J
Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T.
AJNR. American journal of neuroradiology 1992;13(4):1257-9.
1992: Scheltens P; Barkhof F; Valk J; Algra P R; van der Hoop R G; Nauta J; Wolters E C
White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.
Brain : a journal of neurology 1992;115 ( Pt 3)():735-48.
1992: Barkhof F; Valk J; Hommes O R; Scheltens P
Meningeal Gd-DTPA enhancement in multiple sclerosis.
AJNR. American journal of neuroradiology 1992;13(1):397-400.
1992: Barkhof F; Frequin S T; Hommes O R; Lamers K; Scheltens P; van Geel W J; Valk J
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Neurology 1992;42(1):63-7.
1992: Scheltens P; Weinstein H C; Leys D
Neuro-imaging in the diagnosis of Alzheimer's disease. I. Computer tomography and magnetic resonance imaging.
Clinical neurology and neurosurgery 1992;94(4):277-89.
1991: Leys D; Scheltens P; Steinling M
White-matter lesions on CT in Alzheimer patients.
Acta neurologica Scandinavica 1991;84(3):264-5.
1991: Barkhof F; Hommes O R; Scheltens P; Valk J
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.
Neurology 1991;41(8):1219-22.
1991: Scheltens P; Verhey F R; de Boer M; Wolters E C
[Slowly progressive aphasia without dementia]
Nederlands tijdschrift voor geneeskunde 1991;135(20):898-901.
1991: Scheltens P; Visscher F; Van Keimpema A R; Lindeboom J; Taphoorn M J; Wolters E C
Sleep apnea syndrome presenting with cognitive impairment.
Neurology 1991;41(1):155-6.
1991: Barkhof F; Scheltens P; Valk J; Waalewijn C; Uitdehaag B M; Polman C H
Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium- "enhanced" STIR imaging.
Neuroradiology 1991;33(1):70-1.
1990: Scheltens P; Bruyn R P; Hazenberg G J
A Dutch family with autosomal dominant pure spastic paraparesis (Strümpell's disease).
Acta neurologica Scandinavica 1990;82(3):169-73.
1990: Scheltens P; Barkhof F; Valk J; Wolters E C
[Vascular dementia]
Nederlands tijdschrift voor geneeskunde 1990;134(20):1018-9.
1990: Scheltens P; Hazenberg G J; Lindeboom J; Valk J; Wolters E C
A case of progressive aphasia without dementia: "temporal" Pick's disease?
Journal of neurology, neurosurgery, and psychiatry 1990;53(1):79-80.
1989: Scheltens P; Burger C W; Valk J; Bertelsmann F W
Anterolateral lumbar meningocele presenting as an ovarian cyst, in a patient with neurofibromatosis.
Clinical neurology and neurosurgery 1989;91(4):351-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Philip Scheltens

Research Profile (preview)

Disorders

Concepts & Ideas

Anatomy

Chemicals & Drugs

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Philip Scheltens (preview)

All Publications